C. Francès

1.2k total citations
17 papers, 534 citations indexed

About

C. Francès is a scholar working on Rheumatology, Pathology and Forensic Medicine and Pharmacology. According to data from OpenAlex, C. Francès has authored 17 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Rheumatology, 4 papers in Pathology and Forensic Medicine and 3 papers in Pharmacology. Recurrent topics in C. Francès's work include Systemic Lupus Erythematosus Research (6 papers), Autoimmune Bullous Skin Diseases (4 papers) and Drug-Induced Adverse Reactions (3 papers). C. Francès is often cited by papers focused on Systemic Lupus Erythematosus Research (6 papers), Autoimmune Bullous Skin Diseases (4 papers) and Drug-Induced Adverse Reactions (3 papers). C. Francès collaborates with scholars based in France, Austria and Poland. C. Francès's co-authors include Jean‐Charles Piette, M. Rybojad, N. Costedoat‐Chalumeau, D. Sène, Judith Cohen‐Bittan, Jérémie Dion, Gaëlle Leroux, Fredrik Nyberg, Marzia Caproni and Catherine Johanet and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American Academy of Dermatology and Medicine.

In The Last Decade

C. Francès

17 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Francès France 12 410 179 122 62 60 17 534
Rakiba Belkhir France 15 180 0.4× 143 0.8× 159 1.3× 93 1.5× 46 0.8× 28 814
F. Lavie France 10 249 0.6× 78 0.4× 434 3.6× 87 1.4× 98 1.6× 11 879
Cumhur İbrahim Başsorgun Türkiye 11 202 0.5× 140 0.8× 56 0.5× 183 3.0× 24 0.4× 44 466
Joan Maymó Spain 13 475 1.2× 56 0.3× 149 1.2× 73 1.2× 54 0.9× 31 636
S. Grootenboer‐Mignot France 14 394 1.0× 138 0.8× 85 0.7× 220 3.5× 75 1.3× 25 599
Theo Dov Golan Israel 10 308 0.8× 35 0.2× 189 1.5× 60 1.0× 87 1.4× 13 460
Jean‐Charles Piette France 6 290 0.7× 138 0.8× 95 0.8× 108 1.7× 18 0.3× 7 584
Hironari Hanaoka Japan 14 345 0.8× 42 0.2× 121 1.0× 82 1.3× 30 0.5× 74 613
Yukiko Komano Japan 12 268 0.7× 62 0.3× 197 1.6× 71 1.1× 59 1.0× 23 615
Noriyuki Kurata Japan 10 301 0.7× 64 0.4× 146 1.2× 194 3.1× 186 3.1× 27 650

Countries citing papers authored by C. Francès

Since Specialization
Citations

This map shows the geographic impact of C. Francès's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Francès with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Francès more than expected).

Fields of papers citing papers by C. Francès

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Francès. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Francès. The network helps show where C. Francès may publish in the future.

Co-authorship network of co-authors of C. Francès

This figure shows the co-authorship network connecting the top 25 collaborators of C. Francès. A scholar is included among the top collaborators of C. Francès based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Francès. C. Francès is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Moguelet, Philippe, et al.. (2021). Efficacy of tocilizumab in adult H syndrome: a promising therapeutic option. International Journal of Dermatology. 60(10). e417–e419. 3 indexed citations
2.
Arnaud, Laurent, C. Francès, Patricia Senet, et al.. (2020). Long-term efficacy and safety outcomes of lenalidomide for cutaneous lupus erythematosus: A multicenter retrospective observational study of 40 patients. Journal of the American Academy of Dermatology. 84(4). 1171–1174. 14 indexed citations
3.
Moreno‐Sabater, Alicia, Nacéra Ouali, François Chasset, et al.. (2020). Severe onychomycosis management with oral terbinafine in a kidney transplantation setting: Clinical follow‐up by image analysis. Mycoses. 64(3). 309–315. 4 indexed citations
4.
Moguelet, Philippe, Jérôme Bouaziz, Dan Lipsker, et al.. (2018). Livedoid Vasculopathy: A French Observational Study Including Therapeutic Options. Acta Dermato Venereologica. 98(9). 842–847. 20 indexed citations
5.
Sesé, Lucile, H. Gaouar, Jean‐Eric Autegarden, et al.. (2016). Immediate hypersensitivity to iodinated contrast media: diagnostic accuracy of skin tests and intravenous provocation test with low dose. Clinical & Experimental Allergy. 46(3). 472–478. 26 indexed citations
6.
Dion, Jérémie, N. Costedoat‐Chalumeau, D. Sène, et al.. (2016). Relapsing Polychondritis Can Be Characterized by Three Different Clinical Phenotypes: Analysis of a Recent Series of 142 Patients. Arthritis & Rheumatology. 68(12). 2992–3001. 96 indexed citations
7.
Kuhn, Annegret, Elisabeth Aberer, Zsuzsanna Bata‐Csörgõ, et al.. (2016). S2k guideline for treatment of cutaneous lupus erythematosus – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV). Journal of the European Academy of Dermatology and Venereology. 31(3). 389–404. 104 indexed citations
8.
Bessis, D., C. Francès, Nicolas Poulalhon, et al.. (2015). Blisters and Loss of Epidermis in Patients With Lupus Erythematosus. Medicine. 94(46). e2102–e2102. 15 indexed citations
9.
Soria, Ana, et al.. (2015). Fixed Drug Eruption Due to Mesna.. PubMed. 25(6). 444–5. 2 indexed citations
10.
Amsler, E., O. Bayrou, C. Pecquet, & C. Francès. (2012). Five Cases of Contact Dermatitis to a Trendy Pet. Dermatology. 224(4). 292–294. 4 indexed citations
11.
Barète, Stéphane, et al.. (2008). Intravenous immunoglobulins-induced eczematous eruption: A long-term follow-up study. European Journal of Internal Medicine. 20(1). 70–73. 12 indexed citations
12.
Billemont, Bertrand, Stéphane Barète, Philippe Moguelet, et al.. (2008). Skin toxicity of sunitinib: Prospective analysis in patients (pts) with metastatic renal cell carcinoma (mRCC). Journal of Clinical Oncology. 26(15_suppl). 16146–16146. 4 indexed citations
13.
Nazeyrollas, Pierre, et al.. (2003). Efficiency of amifostine as a protection against doxorubicin toxicity in rats during a 12-day treatment.. PubMed. 23(1A). 405–9. 14 indexed citations
14.
Michel, Marc, Catherine Johanet, Olivier Meyer, et al.. (2001). Familial Lupus Erythematosus. Medicine. 80(3). 153–158. 66 indexed citations
15.
Francès, C., et al.. (2001). Dermatologic Manifestations of Relapsing Polychondritis. Medicine. 80(3). 173–179. 108 indexed citations
16.
Francès, C. & J.C. Pietté. (1997). Cutaneous manifestations of Hughes syndrome occurring in the context of lupus erythematosus. Lupus. 6(2). 139–144. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026